AU Stock MarketDetailed Quotes
NOX Noxopharm Ltd
- 0.099
- -0.001-1.00%
20min DelayMarket Closed Dec 27 16:00 AET
28.93MMarket Cap-8.25P/E (Static)
0.099High0.099Low15.57KVolume0.099Open0.100Pre Close1.54KTurnover0.15052wk High0.01%Turnover Ratio292.24MShares0.05152wk Low-0.012EPS TTM19.36MFloat Cap1.590Historical HighLossP/E (Static)195.51MShs Float0.033Historical Low-0.012EPS LYR0.00%Amplitude--Dividend TTM5.21P/B1Lot Size--Div YieldTTM
About Noxopharm Ltd Company
Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms. It is engaged in one segment which is the clinical development in the field of both oncology and non-oncology in the pan-pacific region.
Company Profile
SymbolNOX
Company NameNoxopharm Ltd
Founded2015
MarketASX
Fiscal Year Ends06-30
Address60 Linksley Ave
CityGlenhaven
CountryAustralia
Zip Code2156
Websitehttps://www.noxopharm.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Gisela Mautner
- Chief Executive Officer,Managing Director
- --
- Peter Ashley Marks
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Frederick (Fred) Bart
- Non-Executive Director,Non-Executive Chairman
- --
- Boris Patkin
- Non-Executive Director
- --
Heat List
AU
Overall
Symbol
Price
% Chg
No Data